April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression in Mouse Embryonic Fibroblasts
Author Affiliations & Notes
  • Yuki Morizane
    Retina service, Angiogenesis Laboratory, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Aristomenis Thanos
    Retina service, Angiogenesis Laboratory, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Yusuke Murakami
    Retina service, Angiogenesis Laboratory, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Maki Kayama
    Retina service, Angiogenesis Laboratory, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • George Ttichonas
    Retina service, Angiogenesis Laboratory, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Joan Miller
    Retina service, Angiogenesis Laboratory, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Marc Foretz
    Institut Cochin, Universite Paris Descartes, Paris, France
  • Benoit Viollet
    Institut Cochin, Universite Paris Descartes, Paris, France
  • Demetrios G. Vavvas
    Retina service, Angiogenesis Laboratory, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Yuki Morizane, None; Aristomenis Thanos, None; Yusuke Murakami, None; Maki Kayama, None; George Ttichonas, None; Joan Miller, None; Marc Foretz, None; Benoit Viollet, None; Demetrios G. Vavvas, None
  • Footnotes
    Support  NIH Grant EY014104
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 521. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuki Morizane, Aristomenis Thanos, Yusuke Murakami, Maki Kayama, George Ttichonas, Joan Miller, Marc Foretz, Benoit Viollet, Demetrios G. Vavvas; AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression in Mouse Embryonic Fibroblasts. Invest. Ophthalmol. Vis. Sci. 2011;52(14):521.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Matrix metalloproteinase-9 (MMP-9) plays a critical role in both developmental and pathological ocular tissue remodeling and angiogenesis. Although MMP-9 expression is low in most cells and is tightly controlled, the mechanism of its regulation is poorly understood. We utilized mouse embryonic fibroblasts (MEFs) that were nullizygous for the catalytic α-subunit of AMP-activated protein kinase (AMPK), which is a key regulator of energy homeostasis, to investigate the role of AMPK in the regulation of MMP-9 expression.

Methods: : AMPKα wild type (WT), AMPKα1 or α2 subunit single-knockout (AMPKα1-/- and AMPKα2-/-, respectively), and double knockout of AMPKα1 and AMPKα2 subunit (AMPKα-/-) mouse embryonic fibroblasts (MEFs) were cultured. MEFs were treated with AMPK activators and nuclear factor-ΚB (NF-ΚB) inhibitors, or transduced with adenoviral vector of dominant negative (DN) AMPKα. The level of MMP-9 expression was determined by zymography, ELISA, and quantitative real time PCR.

Results: : Total AMPKα deletion significantly elevated MMP-9 expression compared with WT MEFs (7.8 ± 0.9 times higher in the ELISA, P < 0.01), whereas single knockout of the isoforms AMPKα1 and AMPKα2 caused minimal change. The AMPK activators, 5-amino-4-imidazole carboxamide riboside and A769662, suppressed MMP-9 expression in WT MEFs dose-dependently (P < 0.01) and AMPK inhibition by the over-expression of DN AMPKα elevated MMP-9 expression. In AMPKα-/- MEFs transduced with DN AMPKα, MMP-9 expression was suppressed (P < 0.01). AMPKα-/- MEFs showed constitutive activation of NF-ΚB pathway compared with WT MEFs. Consistently, selective NF-ΚB inhibitors decreased MMP-9 expression in AMPKα-/- MEFs (P < 0.01).

Conclusions: : The energy sensor of the cell, AMPK, suppresses MMP-9 expression by inhibiting the NF-ΚB pathway. AMPK may be a therapeutic target to inhibit pathological tissue remodeling and angiogenesis in the eye.

Keywords: extracellular matrix • metabolism • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×